DIADEMA PARTNERS LP

Position in CUE — Cue Biopharma, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in CUE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$30,359

New position

Shares Held

131,997

first reported quarter

Ownership

3.26%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#16

of 53 holders

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIADEMA PARTNERS LP holds $176,357,038 across 73 Biotechnology names. CUE ranks #70 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	525,181	$17,089,389
2	COGT	Cogent Biosciences, Inc.	322,764	$12,423,186
3	JAZZ	Jazz Pharmaceuticals plc	54,755	$10,351,432
4	TERN	Terns Pharmaceuticals, Inc.	181,752	$9,581,965
5	ABVX	Abivax S.A.	75,944	$8,456,364
6	BMRN	Biomarin Pharmaceutical Inc	148,229	$8,373,456
7	RVMD	Revolution Medicines, Inc.	80,872	$7,864,802
8	KOD	Kodiak Sciences Inc.	192,962	$7,355,711

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,359	131,997	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.